NCT00006352View on ClinicalTrials.gov

Monoclonal Antibody Therapy Plus BCG in Treating Patients With Limited-Stage Small Cell Lung Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

453

Participants

Timeline

Start Date

September 30, 1999

Primary Completion Date

October 31, 2002

Conditions
Lung Cancer
Interventions
BIOLOGICAL

BCG vaccine

BIOLOGICAL

monoclonal antibody BEC2

Trial Locations (1)

1001HV

Vrije Universiteit Medisch Centrum, Amsterdam

All Listed Sponsors
lead

European Organisation for Research and Treatment of Cancer - EORTC

NETWORK

NCT00006352 - Monoclonal Antibody Therapy Plus BCG in Treating Patients With Limited-Stage Small Cell Lung Cancer | Biotech Hunter | Biotech Hunter